TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 1 | -3 | -23 | -30 | -13 | -21 | 0 | -18 |
| P | %wins | 0 | 0 | 0 | 0 | 0 | 100 | 17 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7/29/22 17:01 | 7/27/22 | ACXP | Acurx Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Luci David P | NY | DOT | P,CEO | P.d | 75 | 3.80 | 0 | 20 | 2 | 1,079 | D | ||||||||||||||
11/22/21 16:05 | 11/19/21 | ACXP | Acurx Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Luci David P | NY | DOT | P,CEO | P | 25 | 4.80 | 0 | 5 | 0 | 1,059 | D | ||||||||||||||
3/19/14 12:20 | 3/18/14 | DPRX | Dipexium Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Luci David P | DOT | P,CEO,Se | P.d | 25 | 12.00 | 6 | 2 | 0 | 1,837 | D | -8 | -3 | -23 | -30 | -13 | -21 | 0 | ||||||||
1/4/08 08:48 | 12/31/07 | MACM | Macrochem Corp | DE | Health | Drug | Pharmaceutical Preparations | Luci David P | O | VP | P | 2 | 0.5900 | 0 | 3 | 7 | 45 | D | |||||||||||||||
6/24/04 10:53 | 6/22/04 | BIV | Bioenvision Inc | DE | Health | Drug | Pharmaceutical Preparations | Luci David P | NY | O | See Exhi | P | 8 | 8.25 | 0 | 1 | 14 | 8 | D | ||||||||||||||
11/25/03 13:37 | 11/19/03 | BIV | Bioenvision Inc | DE | Health | Drug | Pharmaceutical Preparations | Luci David P | NY | O | See Exhi | P | 24 | 3.40 | 0 | 7 | New | 7 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |